SLNSW-The role of ixazomib as an augmented conditioning...-TN_cdi_doaj_primary_oai_doaj_org_article_a804debd98c54c009c1516a296fbdf16

The role of ixazomib as an augmented conditioning therapy in salvage autologous stem cell transplant (ASCT) and as a post-ASCT consolidation and maintenance strategy in patients with relapsed multiple myeloma (ACCoRd [UK-MRA Myeloma XII] trial): study protocol for a Phase III randomised controlled trial

Full title: The role of ixazomib as an augmented conditioning therapy in salvage autologous stem cell transplant (ASCT) and as a post-ASCT consolidation and maintenance strategy in patients with relapsed multiple myeloma (ACCoRd [UK-MRA Myeloma XII] trial): study protocol for a Phase III randomised controlled trial

Author/creator: Striha, Alina, Ashcroft, A John, Hockaday, Anna, Cairns, David A, Boardman, Karen, Jacques, Gwen, Williams, Cathy, Snowden, John A, Garg, Mamta, Cavenagh, Jamie, Yong, Kwee, Drayson, Mark T, Owen, Roger, Cook, Mark, Cook, Gordon.

Call Numbers:

Record Identifier: TN_cdi_doaj_primary_oai_doaj_org_article_a804debd98c54c009c1516a296fbdf16

Language: English

Formats: Articles

Publishers: England: BioMed Central Ltd

Permalink: https://collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a804debd98c54c009c1516a296fbdf16

Articles

Articles

Export this record

Export selected records

  • Export to excel
  • Permalink

    • Export record to excel

    File type to download

    Beta version

    Record title

    The role of ixazomib as an augmented conditioning therapy in salvage autologous stem cell transplant (ASCT) and as a post-ASCT consolidation and maintenance strategy in patients with relapsed multiple myeloma (ACCoRd [UK-MRA Myeloma XII] trial): study protocol for a Phase III randomised controlled trial

    Record identifier

    TN_cdi_doaj_primary_oai_doaj_org_article_a804debd98c54c009c1516a296fbdf16

    Record permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a804debd98c54c009c1516a296fbdf16

    Share

    The role of ixazomib as an augmented conditioning therapy in salvage autologous stem cell transplant (ASCT) and as a post-ASCT consolidation and maintenance strategy in patients with relapsed multiple myeloma (ACCoRd [UK-MRA Myeloma XII] trial): study protocol for a Phase III randomised controlled trial

    ACCESS
    https://collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a804debd98c54c009c1516a296fbdf16

    The role of ixazomib as an augmented conditioning therapy in salvage autologous stem cell transplant (ASCT) and as a post-ASCT consolidation and maintenance strategy in patients with relapsed multiple myeloma (ACCoRd [UK-MRA Myeloma XII] trial): study protocol for a Phase III randomised controlled trial

    Full title

    The role of ixazomib as an augmented conditioning therapy in salvage autologous stem cell transplant (ASCT) and as a post-ASCT consolidation and maintenance strategy in patients with relapsed multiple myeloma (ACCoRd [UK-MRA Myeloma XII] trial): study protocol for a Phase III randomised controlled trial

    Author / Creator

    Striha, Alina ; Ashcroft, A John ; Hockaday, Anna ; Cairns, David A ; Boardman, Karen ; Jacques, Gwen ; Williams, Cathy ; Snowden, John A ; Garg, Mamta ; Cavenagh, Jamie ; Yong, Kwee ; Drayson, Mark T ; Owen, Roger ; Cook, Mark ; Cook, Gordon

    Publisher

    England: BioMed Central Ltd

    Journal title

    Trials, 2018, Vol.19 (1), p.169-169

    Record Identifier

    TN_cdi_doaj_primary_oai_doaj_org_article_a804debd98c54c009c1516a296fbdf16

    Language

    English

    Formats

    Articles

    Publication information

    Publisher

    Subjects

    Subjects and topics

    Antineoplastic Agents - administration & dosage Antineoplastic Agents - adverse effects ASCT Augmented ASCT Boron Compounds - administration & dosage Boron Compounds - adverse effects Care and treatment Clinical trials Clinical Trials, Phase III as Topic Corticosteroids Depth of response Diagnosis Diseases Drug Administration Schedule Female Glycine - administration & dosage Glycine - adverse effects Glycine - analogs & derivatives Haematology Health aspects Humans Maintenance Chemotherapy - adverse effects Maintenance Chemotherapy - methods Maintenance Chemotherapy - mortality Male Multicenter Studies as Topic Multiple myeloma Multiple Myeloma - diagnosis Multiple Myeloma - mortality Multiple Myeloma - therapy Neoplasm, Residual Progression-Free Survival Proteasome Inhibitors - administration & dosage Proteasome Inhibitors - adverse effects Quality of Life Randomised Randomized Controlled Trials as Topic Recurrence Relapse Salvage Therapy Stem Cell Transplantation - adverse effects Stem Cell Transplantation - methods Stem Cell Transplantation - mortality Stem cells Study Protocol Time Factors Transplantation Transplantation Conditioning - adverse effects Transplantation Conditioning - methods Transplantation Conditioning - mortality Transplantation, Autologous Treatment Outcome United Kingdom

    More information

    — SCOPE AND CONTENTS

    Contents

    — ALTERNATIVE TITLES

    Full title

    — AUTHORS, ARTISTS AND CONTRIBUTORS

    Author / Creator

    Identifiers

    — PRIMARY IDENTIFIERS

    Record Identifier

    TN_cdi_doaj_primary_oai_doaj_org_article_a804debd98c54c009c1516a296fbdf16

    Permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a804debd98c54c009c1516a296fbdf16

    — OTHER IDENTIFIERS

    ISSN

    E-ISSN

    DOI

    How to access this item

    Online

    1 item

    How to access?

    Login with a Library card

    Full text available >

    About resource >

    View in old catalogue

    Connecting people and collections